Last Updated on May 12, 2025 by The Health Master
Pharmaceutical Plants
Gujarat has once again justified its title of ‘Pharmacy of the Nation‘ as it approved 183 new pharmaceutical plants during FY 2024-25, which is the highest number of allopathic drug manufacturing units approved in a year since the COVID-19 pandemic.
This shows how the vital sector is recovering from pandemic-related impacts with in-house growth.
Pharmaceutical Plants approved since March 2019
This fiscal year is not the only record-breaking approval.
Since March 2019, Gujarat has approved 800+ allopathic drug manufacturing controlled substances, which is the highest number ever, reflecting the state’s pivotal and increasing role in India’s overall pharmaceutical market.
As per H.G. Koshia, Commissioner of the Gujarat Food and Drug Control Administration (FDCA), these new licenses will soon have new plants operational, solidifying the state’s position further on top of an already number one position.
Average investment per plant
In addition to this year’s approval totaling new factories, new financial commitment comes along.
New licenses mean new plants and an average investment of ₹50 crores per unit; however, some companies have invested considerably more when establishing operations in India.
Therefore, from this annual approval alone, the total investment in 2024-25 may reach up to ₹12,000 crores this year alone.
Gujarat’s pharmaceutical ecosystem
Experts from the industry speculate that this strong revenue potential to continue comes from Gujarat’s stasis within the industry to date.
All aspects required for success blend together in great balance—road access, manpower balance, taught ecosystems, and geographical advantages—all provide a give and take for success on top of strong government incentives for business.
In addition, many pharmaceutical plants are shifting from Northern India to Gujarat, which champions this claim as a place with vast business potential.
Gujarat’s contribution
Gujarat also houses medicines produced and transferred significantly through Indian borders.
Currently, Gujarat produces 30% of all medicines consumed solely in India and 28% of all pharmaceutical exports.
In addition, the pharmaceutical industry consists of 4,000+ manufacturing units employing 50,000 people.
Thus, this sector is crucial for growth within Gujarat.
Gujarat’s share in medical devices
Gujarat is also a significant contributor to medically manufactured devices.
Presently 53% of all medical devices manufactured in India hail from Gujarat, and 78% of cardiac stents made across India are from here.
Support from Gujarat Government
The government’s support of pharmaceuticals throughout the years stretches beyond just approvals to things like efforts at bringing investors and attention through the Vibrant Gujarat Global Investor Summit.
Gujarat: The Pharmacy of the Nation
Therefore, these approvals not only solidify previous accomplishments and support future endeavors of what will continue to be India’s Pharmacy of the Nation, but it will also keep on strides into new developments within India.
Q. What is the total number of new allopathic drug plants approved in Gujarat since March 2019?
Over 800 new allopathic drug plants have been approved.
Q. What is the estimated total investment in the new pharmaceutical plants in FY 2024-25?
The projected total investment is approximately ₹12,000 crore.
Q. What percentage of India’s pharmaceutical production comes from Gujarat?
Gujarat contributes 30% of India’s pharmaceutical production.
Q. How many pharmaceutical plants are there in Gujarat?
There are over 4,000 pharmaceutical plants in Gujarat.
Q. What is Vibrant Gujarat’s role in the pharmaceutical sector?
Vibrant Gujarat Global Investor Summit aims to attract further investments and strengthen Gujarat’s position as a global pharmaceutical hub.
Disclaimer: This article contains information obtained from the source mentioned below. Our team made changes in the format to rewrite and present the news or article in a unique format.
Fake QR Codes on Top medicines uncovered in Gujarat
Gujarat FDCA gets 25 Spectrophotometers for Drug Quality Control
USFDA inspection concluded at JB Chemicals and Pharma Gujarat
Gujarat Drug Inspectors Armed with Spectrophotometers for Instant Drug Tests
Gujarat’s Medical Device Park: A Game-Changer for India’s Healthcare Sector
Illegal Clinic Busted in Sonepat for Selling MTP Kit: Haryana
USFDA inspection: At Zydus with 6 observations
Illegal Sale of MTP Kits Busted in Faridabad: FDA Haryana
Drugs and Cosmetics (Compounding of Offences) Rules, 2025: Gist
Haryana hosts Symposium on Dissolution Science
DCA Telangana cracks down on illegal Codeine Syrup Network
Delhi High Court: Cough Syrup Warning Labels Now Required
ICMR recommends ban on Nimesulide for these age groups
Drug recall: Dr Reddy’s and Lupin recall drugs due to these reasons
For informative videos by The Health Master, click on the below YouTube icon:
For informative videos on Medical Store / Pharmacy, click on the below YouTube icon:
For informative videos on the news regarding Pharma / Medical Devices / Cosmetics / Homoeopathy etc., click on the below YouTube icon:
For informative videos on consumer awareness, click on the below YouTube icon:
